André Franken

839 total citations
28 papers, 303 citations indexed

About

André Franken is a scholar working on Cancer Research, Oncology and Molecular Biology. According to data from OpenAlex, André Franken has authored 28 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cancer Research, 18 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in André Franken's work include Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (17 papers) and Single-cell and spatial transcriptomics (5 papers). André Franken is often cited by papers focused on Cancer Cells and Metastasis (17 papers), Cancer Genomics and Diagnostics (17 papers) and Single-cell and spatial transcriptomics (5 papers). André Franken collaborates with scholars based in Germany, Australia and Netherlands. André Franken's co-authors include Hans Neubauer, Tanja Fehm, Dieter Niederacher, F Reinhardt, Nikolas H. Stoecklein, Johannes Fischer, F Meier-Stiegen, Christiane Driemel, Liwen Yang and Volker Endris and has published in prestigious journals such as International Journal of Molecular Sciences, Clinical Chemistry and Virology.

In The Last Decade

André Franken

23 papers receiving 300 citations

Peers

André Franken
Kaitlin Moore United States
Manisha Rao United States
Emilia M. Pulver Netherlands
Shira Yomtoubian United States
Zeqian Yu China
Shijun Ma Singapore
Kaitlin Moore United States
André Franken
Citations per year, relative to André Franken André Franken (= 1×) peers Kaitlin Moore

Countries citing papers authored by André Franken

Since Specialization
Citations

This map shows the geographic impact of André Franken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Franken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Franken more than expected).

Fields of papers citing papers by André Franken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Franken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Franken. The network helps show where André Franken may publish in the future.

Co-authorship network of co-authors of André Franken

This figure shows the co-authorship network connecting the top 25 collaborators of André Franken. A scholar is included among the top collaborators of André Franken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Franken. André Franken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Melanie, Davut Karayel, André Franken, et al.. (2025). Enrichment of Hyaluronic Acid Binding Tumor Cells by Modulation of Selective Adhesion on Microgel Surfaces. Macromolecular Rapid Communications. e00549–e00549.
2.
Rivandi, Mahdi, André Franken, Liwen Yang, et al.. (2024). Miniaturized protein profiling permits targeted signaling pathway analysis in individual circulating tumor cells to improve personalized treatment. Journal of Translational Medicine. 22(1). 848–848. 1 indexed citations
3.
Liu, Hailun, André Franken, Alexandra P. Bielfeld, et al.. (2024). Progesterone-induced progesterone receptor membrane component 1 rise-to-decline changes are essential for decidualization. Reproductive Biology and Endocrinology. 22(1). 20–20. 1 indexed citations
4.
Juratli, Mazen A., Andreas Pascher, Annalen Bleckmann, et al.. (2024). Enhancing Biomarker Detection in Cancer: A Comparative Analysis of Preanalytical Reverse Transcription Enzymes for Liquid Biopsy Application. Laboratory Investigation. 104(10). 102142–102142. 2 indexed citations
5.
Stoecklein, Nikolas H., et al.. (2023). Clinical application of circulating tumor cells. Medizinische Genetik. 35(4). 237–250. 3 indexed citations
6.
Reinhardt, F, Mahdi Rivandi, André Franken, et al.. (2023). DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts. Cancers. 15(22). 5411–5411. 2 indexed citations
7.
Rivandi, Mahdi, Liwen Yang, Ellen Honisch, et al.. (2023). A workflow for the enrichment, the identification, and the isolation of non‐apoptotic single circulating tumor cells for RNA sequencing analysis. Cytometry Part A. 105(4). 242–251. 2 indexed citations
8.
Yang, Liwen, Mahdi Rivandi, André Franken, et al.. (2022). Implementing microwell slides for detection and isolation of single circulating tumor cells from complex cell suspensions. Cytometry Part A. 101(12). 1057–1067. 3 indexed citations
9.
Alberter, Barbara, Bernhard Polzer, Volkmar Müller, et al.. (2021). ViBiBa: Virtual BioBanking for the DETECT multicenter trial program - decentralized storage and processing. Translational Oncology. 14(8). 101132–101132.
10.
Schmidt, Melanie, et al.. (2021). Selective Adhesion and Switchable Release of Breast Cancer Cells via Hyaluronic Acid Functionalized Dual Stimuli-Responsive Microgel Films. ACS Applied Bio Materials. 4(8). 6371–6380. 10 indexed citations
11.
Vasudevan, Ananda Ayyappan Jaguva, et al.. (2021). Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A. Virology. 557. 1–14. 3 indexed citations
12.
Franken, André, Mahdi Rivandi, Liwen Yang, et al.. (2020). A Multiplex PCR-Based Next Generation Sequencing-Panel to Identify Mutations for Targeted Therapy in Breast Cancer Circulating Tumor Cells. Applied Sciences. 10(10). 3364–3364. 3 indexed citations
14.
Krings, Gregor, André Franken, Gertjan T. Sieswerda, et al.. (2019). Safety and efficacy of stenting for aortic arch hypoplasia in patients with coarctation of the aorta. Netherlands Heart Journal. 28(3). 145–152. 5 indexed citations
15.
Kersting, David, André Franken, Charlotte von Gall, et al.. (2019). From in vitro to ex vivo: subcellular localization and uptake of graphene quantum dots into solid tumors. Nanotechnology. 30(39). 395101–395101. 24 indexed citations
16.
Franken, André, Ellen Honisch, F Reinhardt, et al.. (2019). Analysis of ESR1 mutations in single circulating tumor cells from metastatic luminal breast cancer patients upon estrogen deprivation therapy. Senologie - Zeitschrift für Mammadiagnostik und -therapie.
17.
Lampignano, Rita, Liwen Yang, M. Neumann, et al.. (2017). A Novel Workflow to Enrich and Isolate Patient-Matched EpCAMhigh and EpCAMlow/negative CTCs Enables the Comparative Characterization of the PIK3CA Status in Metastatic Breast Cancer. International Journal of Molecular Sciences. 18(9). 1885–1885. 38 indexed citations
18.
Reinhardt, F, André Franken, Tanja Fehm, & Hans Neubauer. (2017). Navigation through inter- and intratumoral heterogeneity of endocrine resistance mechanisms in breast cancer: A potential role for Liquid Biopsies?. Tumor Biology. 39(11). 3726134751–3726134751. 14 indexed citations
19.
Neumann, Martín, André Franken, H Schneck, et al.. (2016). Sequential analysis of circulating tumor cells on genome and protein level: potential regulation of the invasion marker CapG by PIK3CA. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 13(2). 1 indexed citations
20.
Neumann, Martin H., H Schneck, André Franken, et al.. (2016). Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch ® system and the CellCelector . Biotechnology Progress. 33(1). 125–132. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026